Author

Fernande René-Corail

Observed names: F René-Corail, F. Rene-Corail, F. René-Corail, F. Réné-Corail, Fernande RENE-CORAIL, Fernande Rene-Corail, Fernande René-Corail, Fernande Rénée-Corail, Fernande Rénée-Corail

Observed institutions: Centre National de la Recherche Scientifique, Inserm, Sorbonne Paris Cité, Hôpital Cochin, La Ligue Contre le Cancer, Assistance Publique – Hôpitaux de Paris, Hôpital Ambroise-Paré, Institut Cochin, Université Paris Descartes

OpenAlex ID: A5090853126

Integrated genomic characterization of adrenocortical carcinoma

2014 · Guillaume Assié, Eric Letouzé, et al. · Nature Genetics · 732

Mutations of β-Catenin in Adrenocortical Tumors: Activation of the Wnt Signaling Pathway Is a Frequent Event in both Benign and Malignant Adrenocortical Tumors

2005 · Frédérique Tissier, Catherine Cavard, et al. · Cancer Research · 475

Mutations in Regulatory Subunit Type 1A of Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase ( PRKAR1A ): Phenotype Analysis in 353 Patients and 80 Different Genotypes

2009 · Jérôme Bertherat, Anélia Horvath, et al. · The Journal of Clinical Endocrinology & Metabolism · 448

PDF

ARMC5Mutations in Macronodular Adrenal Hyperplasia with Cushing's Syndrome

2013 · Guillaume Assié, Rossella Libé, et al. · New England Journal of Medicine · 396

PDF

Gene Expression Profiling Reveals a New Classification of Adrenocortical Tumors and Identifies Molecular Predictors of Malignancy and Survival

2009 · Aurélien de Reyniès, Guillaume Assié, et al. · Journal of Clinical Oncology · 383

PDF

Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update

2010 · Anélia Horvath, Jérôme Bertherat, et al. · Human Mutation · 175

PDF

Identification of a CpG Island Methylator Phenotype in Adrenocortical Carcinomas

2012 · Olivia Barreau, Guillaume Assié, et al. · The Journal of Clinical Endocrinology & Metabolism · 133

Wnt/β-Catenin Pathway Activation in Adrenocortical Adenomas Is Frequently due to Somatic CTNNB1-Activating Mutations, Which Are Associated with Larger and Nonsecreting Tumors: A Study in Cortisol-Secreting and -Nonsecreting Tumors

2010 · Stéphane Bonnet, Sébastien Gaujoux, et al. · The Journal of Clinical Endocrinology & Metabolism · 133

APRKAR1AMutation Associated with Primary Pigmented Nodular Adrenocortical Disease in 12 Kindreds

2006 · Lionel Groussin, Anelia Horvath, et al. · The Journal of Clinical Endocrinology & Metabolism · 128

Phosphodiesterase 11A (PDE11A) and Genetic Predisposition to Adrenocortical Tumors

2008 · Rossella Libé, Amato Fratticci, et al. · Clinical Cancer Research · 123

Somatic TP53 Mutations Are Relatively Rare among Adrenocortical Cancers with the Frequent 17p13 Loss of Heterozygosity

2007 · Rossella Libè, Lionel Groussin, et al. · Clinical Cancer Research · 115

Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas

2007 · Laure Cazabat, Rossella Libè, et al. · European Journal of Endocrinology · 114

Phosphodiesterase 11A (PDE11A) Gene Defects in Patients with ACTH-Independent Macronodular Adrenal Hyperplasia (AIMAH): Functional Variants May Contribute to Genetic Susceptibility of Bilateral Adrenal Tumors

2012 · Delphine Vezzosi, Rossella Libé, et al. · The Journal of Clinical Endocrinology & Metabolism · 84

PDF

DNA methylation is an independent prognostic marker of survival in adrenocortical cancer

2016 · Anne JOUINOT, Guillaume ASSIE, et al. · The Journal of Clinical Endocrinology & Metabolism · 72

PDF

Systematic Analysis of G Protein-Coupled Receptor Gene Expression in Adrenocorticotropin-Independent Macronodular Adrenocortical Hyperplasia Identifies Novel Targets for Pharmacological Control of Adrenal Cushing’s Syndrome

2010 · Guillaume Assie, Estelle Louiset, et al. · The Journal of Clinical Endocrinology & Metabolism · 57

IGF2 Promotes Growth of Adrenocortical Carcinoma Cells, but Its Overexpression Does Not Modify Phenotypic and Molecular Features of Adrenocortical Carcinoma

2014 · Marine Guillaud-Bataille, Bruno Ragazzon, et al. · PLoS ONE · 52

PDF

Clinical and Pathophysiological Implications of Chromosomal Alterations in Adrenocortical Tumors: An Integrated Genomic Approach

2011 · Olivia Barreau, Aurélien de Reynies, et al. · The Journal of Clinical Endocrinology & Metabolism · 49

Identification of Gene Expression Profiles Associated With Cortisol Secretion in Adrenocortical Adenomas

2013 · Hortense Wilmot Roussel, Delphine Vezzosi, et al. · The Journal of Clinical Endocrinology & Metabolism · 43

Adrenal Pathophysiology: Lessons from the Carney Complex

2005 · Lionel Groussin, Laure Cazabat, et al. · Hormone Research in Paediatrics · 40

Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas

2013 · Bruno Ragazzon, Rossella Libé, et al. · European Journal of Endocrinology · 36

Differential Expression of Parathyroid Hormone–Related Protein in Adrenocortical Tumors: Autocrine/Paracrine Effects on the Growth and Signaling Pathways in H295R Cells

2008 · Marthe Rizk-Rabin, Guillaume Assie, et al. · Cancer Epidemiology Biomarkers & Prevention · 30

2010 · Guillaume Assie, Estelle Louiset, et al. · Molecular Endocrinology · 5

PDF

Dysplasie micronodulaire pigmentée des surrénales et complexe de Carney

2005 · L. Cazabat, L. Groussin, et al. · Annales d Endocrinologie · 4

2010 · Guillaume Assie, Estelle Louiset, et al. · Endocrine Reviews · 3

Molecular classification of benign adrenocortical tumors: an integrated genomic study

2018 · Simon Faillot, Mario Neou, et al. · Endocrine Abstracts

Works count: 54

Citation count: 3,830

H-index: 21

I10-index: 21